# EDGAR Filing Document

**Accession Number:** 0001716166
**File Stem:** 0001493152-23-004278
**Filing Date:** 2023-2
**Character Count:** 9322
**Document Hash:** 596bea95e30e4d3bc3d4ccda1ac72e9e
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-23-004278.hdr.sgml**: 20230210

**ACCESSION NUMBER**: 0001493152-23-004278

**CONFORMED SUBMISSION TYPE**: SC 13G/A

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20230210

**DATE AS OF CHANGE**: 20230210

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Vivos Therapeutics, Inc.
- **CENTRAL INDEX KEY:** 0001716166
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **IRS NUMBER:** 813224056
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SC 13G/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-92230
- **FILM NUMBER:** 23611771

**BUSINESS ADDRESS:**
- **STREET 1:** 7921 SOUTHPARK PLAZA,
- **STREET 2:** SUITE 210
- **CITY:** LITTLETON
- **STATE:** CO
- **ZIP:** 80120
- **BUSINESS PHONE:** (866)908-4867

**MAIL ADDRESS:**
- **STREET 1:** 7921 SOUTHPARK PLAZA,
- **STREET 2:** SUITE 210
- **CITY:** LITTLETON
- **STATE:** CO
- **ZIP:** 80120

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Vivos BioTechnologies, Inc.
- **DATE OF NAME CHANGE:** 20170901
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Huntsman Ronald Kirk
- **CENTRAL INDEX KEY:** 0001835498

**FILING VALUES:**
- **FORM TYPE:** SC 13G/A

**MAIL ADDRESS:**
- **STREET 1:** 9137 RIDGELINE BOULEVARD, SUITE 135
- **CITY:** HIGHLANDS RANCH
- **STATE:** CO
- **ZIP:** 80129

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549**

**SCHEDULE 13G/A**

**(Amendment No. 2)**

**UNDER THE SECURITIES EXCHANGE ACT OF 1934**

**VIVOS THERAPEUTICS, INC.**

(Name of Issuer)

**Common stock, par value $0.0001 per share**

(Title of Class of Securities)

**92859108**

(CUSIP Number)

**December 31, 2022**

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

☐ Rule 13d-1(b) <br> ☐ Rule 13d-1(c) <br> ☒ Rule 13d-1(d)

\* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

CUSIP 92859E108

1. Name
 of Reporting Persons Coronado V Partners, LLC

2. Check
 the Appropriate Box if a Member of a Group (See Instructions) (a)
 ☐ (b) ☐

3. SEC
 Use Only

4. Citizenship
 or Place of Organization Wyoming

---

| | | |
|:---|:---|:---|
| Number of<br> Shares<br> Beneficially<br> Owned By<br> Each<br> Reporting<br> Person<br> With: | 5. | Sole Voting Power<br>1,740,000<sup>(1)</sup> |
| Number of<br> Shares<br> Beneficially<br> Owned By<br> Each<br> Reporting<br> Person<br> With: | 6. | Shared Voting Power<br>0 |
| Number of<br> Shares<br> Beneficially<br> Owned By<br> Each<br> Reporting<br> Person<br> With: | 7. | Sole Dispositive Power<br>1,740,000<sup>(1)</sup> |
| Number of<br> Shares<br> Beneficially<br> Owned By<br> Each<br> Reporting<br> Person<br> With: | 8. | Shared Dispositive Power<br>0 |

---

9. Aggregate
 Amount Beneficially Owned by Each Reporting Person 1,740,000<sup>(1)</sup>

10. Check
 if the Aggregate Amount in Row (9) Excludes Certain Shares

11. Percent
 of Class Represented by Amount in Row (9) 6.0% <sup>(1)</sup>

12. Type
 of Reporting Person (See Instructions) OO

(1) See Item 4.

CUSIP 92859E108

1. Names
 of Reporting Persons R. Kirk Huntsman

2. Check
 the Appropriate Box if a Member of a Group (See Instructions) (a)
 ☐ (b) ☐

3. SEC
 Use Only

4. Citizenship
 or Place of Organization United
 States

---

| | | |
|:---|:---|:---|
| Number of<br> Shares<br> Beneficially<br> Owned By<br> Each<br> Reporting<br> Person<br> With: | 5. | Sole Voting Power<br>2,250,834<sup>(1)</sup> |
| Number of<br> Shares<br> Beneficially<br> Owned By<br> Each<br> Reporting<br> Person<br> With: | 6. | Shared Voting Power<br>0 |
| Number of<br> Shares<br> Beneficially<br> Owned By<br> Each<br> Reporting<br> Person<br> With: | 7. | Sole Dispositive Power<br>2,250,834<sup>(1)</sup> |
| Number of<br> Shares<br> Beneficially<br> Owned By<br> Each<br> Reporting<br> Person<br> With: | 8. | Shared Dispositive Power<br>0 |

---

9. Aggregate
 Amount Beneficially Owned by Each Reporting Person 2,250,834<sup>(1)</sup>

10. Check
 if the Aggregate Amount in Row (9) Excludes Certain Shares

11. Percent
 of Class Represented by Amount in Row (9) 9.0%<sup>(1)</sup>

12. Type
 of Reporting Person (See Instructions) IN

(1) See Item 4.

---

| | |
|:---|:---|
| **Item 1(a).** | **Name of Issuer** |

---

Vivos Therapeutics, Inc. (the "Issuer")

---

| | |
|:---|:---|
| **Item 1(b).** | **Address of the Issuer's Principal Executive Offices** |

---

7921 Southpark Plaza, Suite 210

Littleton, Colorado 80120

---

| | |
|:---|:---|
| **Item 2(a).** | **Names of Persons Filing** |

---

Coronado V Partners, LLC and R. Kirk Huntsman (collectively, the "Reporting Persons")

---

| | |
|:---|:---|
| **Item 2(b).** | **Address of the Principal Business Office, or if none, Residence:** |

---

7921 Southpark Plaza, Suite 210

Littleton, Colorado 80120

---

| | |
|:---|:---|
| **Item 2(c).** | **Citizenship** |

---

Coronado V Partners, LLC is a Wyoming limited liability company. R. Kirk Huntsman is a citizen of the United States of America.

---

| | |
|:---|:---|
| **Item 2(d).** | **Title of Class of Securities** |

---

Common stock, $0.0001 par value per share.

---

| | |
|:---|:---|
| **Item 2(e).** | **CUSIP Number** |

---

92859E108

**Item 3.** **If this statement is filed pursuant to Rules <u>13d-1(b),</u> or <u>13d-2(b)</u> or (c), check whether the person filing is a:**

---

| | |
|:---|:---|
| ☐ | (a) Broker or Dealer registered under Section 15 of the Exchange Act. |
| ☐ | (b) Bank as defined in Section 3(a)(b) or the Exchange Act. |
| ☐ | (c) Insurance company as defined in Section 3(a)(19) of the Exchange Act. |
| ☐ | (d) Investment company registered under Section 8 of the Investment Company Act. |
| ☐ | (e) An Investment adviser in accordance with Rule 13d-1 (b)(1)(ii)(e). |
| ☐ | (f) An employee benefit plan or endowment fund in accordance with Rule 13d 1(b)(1)(ii)(f). |
| ☐ | (g) A Parent Holding Company or control person in accordance with Rule 13d 1(b)(1)(ii)(g). |
| ☐ | (h) A Savings Association as defined in Section 3(b) of the Federal Deposit Insurance Act. |
| ☐ | (i) A Church Plan that is excluded from the definition of an investment company under Section 3 (c)(14) of the Investment Company Act. |
| ☐ | (j) Group, in accordance with Rule 13d-1 (b)(1)(ii)(j). |
|  | Not applicable. |

---

**Item 4.** **Ownership**

The responses to Items 5-10 of the cover pages of this Schedule 13G are incorporated herein by reference.

As of February 10, 2023, Coronado V Partners, LLC and R. Kirk Huntsman may be deemed to beneficially own 1,740,000 shares and 2,250,834 shares, respectively, of the Issuer's common stock, representing 6.0% and 9.0%, respectively, of the total shares of common stock issued and outstanding.

The percentages of the shares of common stock held by the Reporting Persons are based on 25,012,119 shares of common stock issued and outstanding as of February 10, 2023.

As of February 10, 2023, Coronado V Partners, LLC is the record holder of 1,740,000 shares of common stock. R. Kirk Huntsman is the record holder of 510,834 shares of common stock. R. Kirk Huntsman is the president of Coronado V Partners, LLC and has voting and investment discretion with respect to the common stock held of record by Coronado V Partners, LLC. As such, Mr. Huntsman may be deemed to have beneficial ownership of the securities held of record by Coronado V Partners, LLC. The 510,834 shares held of record by Mr. Huntsman include 463,334 shares which may be purchased by exercising an option to purchase such shares, which 438,334 option is presently exercisable.

**Item 5.** **Ownership of Five Percent or Less of a Class**

Not applicable.

**Item 6.** **Ownership of More than Five Percent on Behalf of Another Person**

Not applicable.

**Item 7.** **Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person**

Not applicable.

**Item 8.** **Identification and Classification of Members of the Group**

Not applicable.

**Item 9.** **Notice of Dissolution of Group**

Not applicable.

**Item 10.** **Certification**

Not applicable.

**SIGNATURE**

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date: February 10, 2023

---

| | |
|:---|:---|
| **Coronado V Partners, LLC** | **Coronado V Partners, LLC** |
| By: | */s/ R. Kirk Huntsman* |
| Name: | R. Kirk Huntsman |
| Title: | President |

---

---

| |
|:---|
| */s/ R. Kirk Huntsman* |
| **R. Kirk Huntsman** |

---